Global Hormone Replacement Therapy Market - Growth, Trends and Forecast 2017 - 2022

  • ID: 4388384
  • Report
  • Region: Global
  • 205 pages
  • Mordor Intelligence
1 of 4
The Global market for Hormone Replacement Therapy (HRT) Market is expected to reach $XX by the end of 2020 growing at a CAGR of around XX% from 2015 to 2021. Hormone Replacement therapy is the management of hormones by external administration due to diminished secretion in the body or no secretion in the body of an individual. The therapy usually is initiated at menopause. Estrogen, Progesterone is administered in the body to reduce the symptoms of menopause. However, there are risk and adverse effects in Hormone replacement therapy like, risk of breast cancer, cervical cancer, uterine cancer, bowel caner, etc.

The market have been divided into three segments based on therapeutics i.e. Estrogen Replacement Market, Growth Hormone Replacement therapy and Thyroid hormone replacement therapy. The Estrogen Replacement therapy generates the largest revenue in the market and is administered mostly to post-menopausal women. The Growth Hormone replacement therapy is applicable mainly to children. The Hormone replacement therapy gained its more use in treatment of anti-aging and vaginal estrogen therapy. The market have been further segmented based on various dosage forms like Orals (Tablets. Capsules), Injectable, transdermal delivery and others. New formulations like, transdermal drugs, gels and creams with increased bioavailability is boosting the hormone replacement therapy market. It has also been observed that there are wide advantages of HRT like reduction in risk of cardiovascular diseases, osteoporosis etc.

North America is the largest market for the HRT, followed by Europe, Asia-pacific, Latin America and others. The market sees a rapid growth in HRT majorly due to advancement of healthcare industry in Asian countries like China and India. Increasing awareness of post-menopausal hazards and trend for anti-aging treatment augments the market senario. The key players in hormone replacement therapy market are Bayer AG, Abbott Laboratories, Actavis Plc., Merck &Co. Inc. Novo Nordisk, Mylan Laboratories, QuatRx Pharmaeuticals, Novartis AG etc.


Increasing awareness on post-menopausal hazards, increasing anti-aging therapy, new formulations boosting the market.


High risk of Cancer, blood clotting. High cost of therapy.

This Report Offers:

1) Market Definition for the specified topic along with identification of key drivers and restraints for the market.

2) Market analysis for the Global Hormone Replacement Therapy Market, with region specific assessments and competition analysis on a global and regional scale.

3) Identification of factors instrumental in changing the market scenarios, rising prospective opportunities and identification of key companies which can influence the market on a global and regional scale.

4) Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market shares

5) Identification and analysis of the Macro and Micro factors that affect the Hormone Replacement Therapy Market on both global and regional scale.

6) A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
Note: Product cover images may vary from those shown
2 of 4
1. Introduction
1.1 Study Deliverables
1.2 Market Definition
1.3 Sizing Units
1.4 Base Currency
1.5 Review and Forecast Period Years
1.6 General Study Assumptions
1.7 Report Description
2. Research Methodology
2.1 Introduction
2.2 Analysis Methodology
2.3 Econometric Forecast Model
3. Executive Summary
4. Key Inferences
5. Market Characterization
5.1 Current Market Scenario
5.2 Market Overview
5.2.1 Market Drivers Increasing awareness amongst women on post menopausal hazards Increasing Patient Pool for hormone replacement Introduction of new drug delivery systems
5.2.2 Market Restraints High cost of hormone replacement therapy High risk of cancer associated with hormone replacement therapy
5.2.3 Market Challenge Reimbursement issues - Women are less likely to be reimbursed for hormone therapy
5.2.4 Market Opportunity Increasing Trend of Sex Reassignment
6. Market Segmentation
6.1 By Therapy
6.1.1 Estrogen Replacement Market
6.1.2 Growth Replacement Hormone Market
6.1.3 Thyroid Hormone Replacement Therapy
6.1.4 Testosterone replacement therapy
6.2 By Route Of Administration
6.2.1 Oral Route
6.2.2 Parenteral Route
6.2.3 Transdermal Route
6.2.4 Injectables - Intramuscular & Subcutaneous
6.2.5 Other Route Based Hormone Replacement Therapy
6.3 By Type of Disease
6.3.1 Menopause
6.3.2 Hypothyroidism
6.3.3 Male Hypogonadism
6.3.4 Growth Hormone Deficiency
7. Global Market: Geographical Landscape
7.1 North America
7.1.1 USA
7.1.2 Canada
7.1.3 Mexico
7.2 Europe
7.2.1 UK
7.2.2 Germany
7.2.3 France
7.2.4 Spain
7.3 Asia Pacific
7.3.1 China
7.3.2 Japan
7.3.3 India
7.3.4 Australia
7.3.5 South Korea
7.3.6 Others
7.4 Middle East & Africa
7.4.1 GCC
7.4.2 South Africa
7.4.3 Others
7.5 Latin America
7.5.1 Brazil
7.5.2 Argentina
7.5.3 Others
8. Industry Analysis
8.1 Porter’s Five Forces
8.1.1 Bargaining Power of Suppliers
8.1.2 Bargaining Power of Consumers
8.1.3 Threat of New Entrants
8.1.4 Threat of Substitute Products and Services
8.1.5 Competitive Rivalry within the Industry
9. Competitive Landscape
9.1 Mergers & Acquisitions
9.2 Agreements, Collaborations & Partnerships
9.3 New Product Launches
9.4 Recommendations to new market players
10. Key Players
10.1 F. Hoffmann-La Roche
10.2 Merck Serono
10.3 Novartis
10.4 Novo Nordisk
10.5 Pfizer
10.6 Bayer AG
10.7 Abbott Laboratories
10.8 Actavis Plc
10.9 Hisamitsu Pharmaceutical Co. Inc.
10.10 Mylan Laboratories
10.11 Teva Pharmaceuticals
11. Future Outlook
Note: Product cover images may vary from those shown
3 of 4


4 of 4
Note: Product cover images may vary from those shown